Seattle Genetics ($SGEN) is looking to recruit roughly 100 new workers throughout its operations, the company said, accelerating its pipeline of armed antibody candidates. The biotech is dialing up its R&D budget in 2015, executives told the Seattle Business Journal, following through on partnering agreements and pushing early-stage candidates into clinical trials. More